1993

In June 1993, Bristol-Myers Squibb Company joined Sterling Winthrop Inc. and their partner Sanofi-Synthelabo Inc. in a joint venture partnership for the development and marketing of two promising compounds, Plavix® and Avapro/Avalide®.